期刊文献+

Hsa-miR-150过表达诱导弥漫大B淋巴瘤细胞系OCI-Ly10再分化 被引量:3

Over-expression of hsa-miR-150 induces re-differentiation of diffuse large B-cell lymphoma cell line OCI-Ly10
下载PDF
导出
摘要 目的:探究hsa-miR-150过表达诱导弥漫大B淋巴瘤细胞系OCI-Ly10再分化的机制。方法:运用real-time PCR检测hsa-miR-150在永生化CD19+B细胞和OCI-Ly10细胞中的表达,利用Western blotting和免疫荧光细胞化学检测hsa-miR-150靶基因c-myb的表达;通过LipofectamineTM2000脂质体法将含有重组慢病毒质粒的病毒上清转染OCI-Ly10细胞(Ly10-control组和Ly10-miR-150组);对新构建的细胞亚系,通过MTT法检测细胞增殖能力,流式细胞术检测细胞周期及凋亡;运用real-time PCR、免疫荧光细胞化学和Western blotting检测Ly10-control和Ly10-miR-150的B细胞分化相关基因及c-Myb的表达;利用干扰片段干扰OCI-Ly10细胞c-myb表达后,运用real-time PCR和Western blotting检测干扰效率及干扰后转录调节因子BCL6和浆细胞分化开关蛋白PRDM1的表达。结果:(1)CD19+B淋巴细胞的hsa-miR-150表达量明显高于OCI-Ly10细胞(P<0.05);c-Myb在OCI-Ly10细胞中表达较强,而在CD19+B淋巴细胞表达较弱。(2)OCI-Ly10细胞经转染hsa-miR-150后,B细胞分化相关基因的表达都明显发生了变化,B细胞特异性激活蛋白(PAX5)和BCL6表达下调(P<0.05);干扰素调节因子4(IRF4)、PRDM1和X盒结合蛋白1(XBP1)的表达上调(P<0.05);和对照组相比,c-Myb在Ly10-miR-150细胞中表达明显下调(P<0.05)。(3)干扰OCI-Ly10细胞c-myb表达后,BCL6表达明显下调,而PRDM1表达明显上调。结论:(1)hsa-miR-150过表达对OCI-Ly10细胞抑制增殖和诱导凋亡作用非常明显。(2)过表达hsa-miR-150可诱导该瘤细胞向末端B细胞方向分化,作用机制可能与下调其靶基因c-myb的表达有关。 AIM: To investigate the mechanism that over-expression of hsa-miR-150 induces the re-differentia- tion of diffuse large B-cell lymphoma cell line OCI-Ly10. METHODS : The expression level of hsa-miR-150 in CD19^+ B and OCI-Ly10 cell lines was detected by real-time PCR. The expression level of c-Myb was detected by Western blotting and immunofiuorescence cytochemistry methods. Lentiviral supernatant containing recombinant plasmids was transfected in- to OCI-Ly10 cells by Lipofectamine^TM 2000 and named Ly10-control and Ly10-miR-150. The biological functions of the 2 cell sublines were identified by MTr assay. The cell cycle and apoptotic rates were detected by flow cytometry. The expres- sion levels of B-lymphocyte differentiation-related genes and c-myb in Ly10-control and Ly10-miR-150 cells were detected by real-time PCR and Western blotting. When c-myb was interfered in by interference fragment in OCI-Ly10 cells, the in- terference efficiency and the expression levels of BCL6 and PRDM1 were detected by real-time PCR and Western blotting. RESULTS: The expression level of hsa-miR-150 in CD19^+ B cells was significantly higher than that in OCI-LyI0 cells. The expression level of c-Myb in OCI-Ly10 cells was higher than that in CD19^+ B cells. The expression levels of B-lympho- cyte differentiation-related genes were changed significantly in OCI-Ly10 cells after transfected with hsa-miR-150. The ex- pression levels of PAXS, BCI/5 and c-Myb in Ly10-miR-150 cells were lower than those in Ly10-control cells, but the ex- pression levels of IRF4, PRDM1 and XBP1 were higher than those in Ly10-control cells. The expression level of BCL6 was lower and PRDM1 was higher after interference. CONCLUSION: Hsa-miR-150 plays a significant role in inhibiting prolif- eration and inducing apoptosis of OCI-Ly10 cells. The mechanism that over-expression of hsa-miR-150 induces OCI-Ly10 cell differentiation toward terminal B cells may be related to the down-regulation of c-myb.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2014年第2期226-232,共7页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81272634)
关键词 弥漫大B细胞淋巴瘤 分化 Hsa—miR-150 基因 c-myb Diffuse large B-cell lymphoma Differentiation Hsa-miR-150 Genes, c-myb
  • 相关文献

参考文献14

  • 1Balague 0, Mozos A,Martinez D, et al. Activation of theendoplasmic reticulum stress-associated transcription factorX box-binding protein-1 occurs in a subset of normal ger-minal-center B cells and in aggressive B-cell lymphomaswith prognostic implications [ J]. Am J Pathol, 2009,174(6):2337-2346.
  • 2Mishra PJ,Merlino G. MicroRNA reexpression as differ-entiation therapy in cancer[ J]. J Clin Invest,2009,119(8):2119-2123.
  • 3Zhou B, Wang S, Mayr C, et al. miR-150, a microRNAexpressed in mature B and T cells,blocks early B cell de-velopment when expressed prematurely [ J]. Proc NatlAcad Sci U S A,2007,104( 17) :7080-7085.
  • 4Malumbres R, Sarosiek KA, Cubedo E, et al. Differentia-tion stage-specific expression of microRNAs in B lympho-cytes and diffuse large B-cell lymphomas [ J]. Blood,2009,113(16) :3754-3764.
  • 5Chen SH, Wang ZQ, Dai XZ, et al. Re-expression of mi-croRNA-150 induces EBV-positive Burkitt lymphoma dif-ferentiation by modulating c-Myb in vitro[ J]. Cancer Sci,2013 ,104(7) :826-834.
  • 6张铁成,周晓燕,于宝华,张太明,施达仁.AKT蛋白激酶活化对弥漫性大B细胞淋巴瘤细胞生物学行为影响的体外研究[J].中华病理学杂志,2007,36(5):318-323. 被引量:4
  • 7Auer RL. The coming of age of microRNA for B cell lym-phomas [J]. Histopathology,2011,58(1) :39-48.
  • 8Xiao C, Calado DP, Galler G, et al. MiR-150 controls Bcell differentiation by targeting the transcription factor c-Myb[J]. Cell,2007,131(1) :146-159.
  • 9Kallies A, Hasbdd J, Fairfax K, et al. Initiation of plas-ma cell differeraiation is independent of the transcriptionfactor Blimp-1 [ J]. Immunity, 2007, 26(5) : 555-566.
  • 10Calame KL, Lin KI, Tunyaplin C. Regulatory mechanismsthat determine the development and function of plasmacells[ J]. Annu Rev Immunol,2003,21:205-230.

二级参考文献27

  • 1Coiffier B. Diffuse large cell lymphoma. Curt Opin Oncol, 2001, 13(5) : 325-334.
  • 2Garter KC. Diffuse large B-cell lylnphoma.// Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon : IARC Press,2001:171-172.
  • 3Ree H J, Ohsima K, Aozasa K,et al. Detection of germinal center B-cell lymphoma in archival specimens : critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil. Hum Pathol, 2003, 34(6) : 610-616.
  • 4Bellacosa A, Testa JR, Staal SP, et al. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science, 1991, 254 (5029) :274-277.
  • 5Chang HW, Aoki M, Fruman D, et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science, 1997, 276 ( 5320 ) : 1848-1850.
  • 6Osaki M, Oshimura M, Ito H. PI3 K-Akt pathway : its functions and alterations in human cancer, Apoptosis, 2004, 9 ( 6 ) : 667- 676.
  • 7Zhou X, Tan M, Stone Hawthorne V, et al. Activation of the Akt/ mammalian target of rapamycin/gE-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancer. Chn Cancer Res, 2004,10(20) :6779-6788.
  • 8Grewe M, Gansauge F, Schmid RM, et al. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP- p70S6K pathway in human pancreatic cancer cells. Cancer Res, 1999,59( 15 ) :3581-3587.
  • 9Nieborowska-Skorska M, Slupianek A, Xue L, et al. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells. Cancer Res, 2001,61 (17) :6517-6523.
  • 10Dutton A, Reynolds GM, Dawson CW, et al. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin' s lymphoma cells through a mechanism involving Akt kinase and mTOR. J Pathol, 2005, 205 (4) :498- 506.

共引文献3

同被引文献34

  • 1王万里,郭淑利,王慧睿.微小RNA-92a靶向FHIT基因调控淋巴瘤细胞增殖及凋亡的机制研究[J].中华生物医学工程杂志,2019,25(2):177-182. 被引量:2
  • 2Fatica A, Fazi F. MicroRNA-regulated pathways in hema- tological malignancies: how to avoid cells playing out of tune[J~. Int J Mol Sci, 2013, 14(10) :20930-20953.
  • 3Ling H, Fabbri M, Calin GA. MicroRNAs and other non- coding RNAs as targets for anticancer drug development [J]. Nat Rev Drug Discov, 2013, 12( 11 ):847-865.
  • 4He Y, Jiang X, Chen J. The role of miR-150 in normal and malignant hematopoiesis [ J ]. Oncogene, 2014, 33 (30) :3887-3893.
  • 5Kannan M, Mohan KV, Kulkarni S, et al. Membrane ar- ray-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis[ J]. Transfusion, 2009, 49 (7) : 1443-1450.
  • 6Chung EY, Dews M, Cozma D, et al. c-Myb oncoprotein is an essential target of the d/eu2 tumor suppressor micro- RNA cluster[J]. Cancer Biol Ther, 2008, 7( 11 ) :1758- 1764.
  • 7Nana-Sinkam SP, Croce CM. MicroRNA in chronic lym- phocytic leukemia: transitioning from laboratory-based in- vestigation to clinical application [ J ]. Cancer Genet Cyto- genet, 2010, 203 (2) : 127-133.
  • 8Willimott S, Wagner SD. Post-transcriptional and post- translational regulation of Bcl2 [ J ]. Biochem Soc Trans, 2010, 38(6) :1571-1575.
  • 9Vasilatou D, Papageorgiou S, Pappa V, et al. The role of microRNAs in normal and malignant hematopoiesis [ J ]. Eur J Haematol, 2010, 84( 1 ) : 1-16.
  • 10Pattabiraman DR, Gonda TJ. Role and potential for thera- peutic targeting of MYB in leukemia [ J ]. Leukemia, 2013, 27(2) :269-277.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部